Abbott Diabetes Care v Powell Gilbert LLP (CoA, 9 January 2025)
| Date | 9 January 2025 |
|---|---|
| Court | CoA |
| Division | Luxembourg (LU) |
| Type of action | Appeal RoP220.2 |
| Registry reference | APL_46747/2024 · ORD_67618/2024 |
| Parties | Abbott Diabetes Care Inc. v. Powell Gilbert LLP |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By order of 9 January 2025 (UPC_CoA_480/2024 and UPC_CoA_481/2024), the Court of Appeal dismissed Abbott Diabetes Care’s appeal against two orders of The Hague Local Division of 29 July 2024 granting Powell Gilbert, acting as a member of the public, access to the pleadings and evidence in two sets of provisional measures proceedings (EP 2 713 879 and EP 3 831 283) between Abbott and Sibionics. The Court holds that once the first-instance decision has been given, a pending appeal no longer justifies refusing access to protect the integrity of proceedings. The order builds on Ocado v Autostore.
Question
May public access to pleadings and evidence under Rule 262.1(b) be refused while an appeal is pending, or where the decision concerns provisional measures and parallel proceedings exist?
Decision
The request must state its purpose and explain why access is necessary, so that the interests under Art. 45 UPCA can be weighed (paragraphs 9 and 10), those interests include the integrity of proceedings and public order (paragraph 11). The public interest generally arises once a decision is given (paragraphs 12 and 13). Once the first instance has decided, withholding access no longer protects the integrity of its proceedings, even if an appeal is or may be lodged (paragraphs 14 and 16 to 18). The CJEU judgment in API v Commission (C-514/07) is distinguished (paragraph 15). The same principles apply to provisional measures, to later merits proceedings and to proceedings on the same patent or family (paragraphs 19 and 20). As Abbott sought no redactions, the balance favoured access (paragraphs 22 and 23).
Key points for practice
- A party wishing to limit access to its pleadings must ask for specific protection (confidentiality, personal data): a pending appeal is not enough.
- An interest in better understanding the decision suffices to support a third party’s request (paragraph 22).
Provisions applied
- Agreement on a Unified Patent Court
- Art. 45
- Rules of Procedure
- Rules 262.1 and 262.2
- Case law cited
- Ocado v Autostore, Court of Appeal, 10 April 2024, NJOY v Juul Labs, Paris Central Division, 24 April 2024 (relied on by Abbott), CJEU, 21 September 2010, API v Commission, C-514/07
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: UPC Court of Appeal.
Dhenne Avocats blog: UPC Appeals: What the Numbers Show.
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- claimantAbbott Diabetes Care Inc.36 decisions in the corpusFollow this party
- defendantPowell Gilbert LLP4 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
Contents of the record
- Nature of the act
- Appeal RoP220.2
- Outcome (Dhenne Avocats summary)
- La cour d’appel rejette l’appel d’Abbott et confirme l’accès de Powell Gilbert aux écritures et pièces de deux procédures de mesures provisoires, l’appel pendant ne justifiant pas un refus.
- Appeal
- Decision of the Court of Appeal.
- Instance
- Court of Appeal decision.
Patents mentioned
EP 2 713 879mentioned in: Dhenne Avocats analysis Follow this patentEP 3 831 283mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Ocado Innovation v Autostore (CoA, 10 April 2024) cited in this record
- Dolby International v Optoma Deutschland (CFI, 28 July 2026) cites this decision
- Vereenigde Octrooibureaux v Dolby International (CFI, 24 July 2026) cites this decision
- Franz Kaldewei v Bette (CFI, 23 July 2026) cites this decision
- Huawei v MediaTek (CFI, UPC_CFI_1235/2025, 26 March 2026) cites this decision
- Huawei v MediaTek (CFI, UPC_CFI_1234/2025, 26 March 2026) cites this decision
- Gowling WLG v ZENTIVA PORTUGAL (CFI, 6 March 2026) cites this decision
- Herbert Smith Freehills Kramer (applicant) in Insulet v EOFLow (CoA, 22 December 2025) cites this decision
- Taylor Wessing v NEC (CFI, 26 August 2025) cites this decision
- Renault v Avago Technologies International Sales (CFI, 30 July 2025) cites this decision
- NJOY Netherlands v Juul Labs International (CFI, 9 June 2025) cites this decision
- Dolby International v Beko Germany (CFI, 9 April 2025) cites this decision
Patents and standards
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.